Swiss National Bank’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $191M | Buy |
652,220
+35,160
| +6% | +$11.6M | 0.11% | 165 |
|
|
2025
Q4 | $216M | Sell |
617,060
-34,240
| -5% | -$11.6M | 0.13% | 115 |
|
|
2025
Q3 | $210M | Sell |
651,300
-34,000
| -5% | -$10.6M | 0.12% | 135 |
|
|
2025
Q2 | $267M | Buy |
685,300
+31,100
| +5% | +$12.5M | 0.16% | 109 |
|
|
2025
Q1 | $285M | Sell |
654,200
-900
| -0.1% | -$361K | 0.2% | 85 |
|
|
2024
Q4 | $242M | Sell |
655,100
-34,700
| -5% | -$14.5M | 0.16% | 98 |
|
|
2024
Q3 | $359M | Buy |
689,800
+900
| +0.1% | +$481K | 0.23% | 68 |
|
|
2024
Q2 | $373M | Sell |
688,900
-14,700
| -2% | -$7.77M | 0.26% | 66 |
|
|
2024
Q1 | $365M | Sell |
703,600
-33,300
| -5% | -$16.6M | 0.26% | 68 |
|
|
2023
Q4 | $347M | Sell |
736,900
-25,600
| -3% | -$11.8M | 0.26% | 68 |
|
|
2023
Q3 | $332M | Sell |
762,500
-94,400
| -11% | -$42.8M | 0.26% | 69 |
|
|
2023
Q2 | $381M | Sell |
856,900
-90,900
| -10% | -$41.9M | 0.26% | 70 |
|
|
2023
Q1 | $436M | Sell |
947,800
-27,600
| -3% | -$13.1M | 0.3% | 63 |
|
|
2022
Q4 | $500M | Sell |
975,400
-69,432
| -7% | -$35.3M | 0.36% | 57 |
|
|
2022
Q3 | $475M | Sell |
1,044,832
-1,900
| -0.2% | -$909K | 0.34% | 52 |
|
|
2022
Q2 | $505M | Sell |
1,046,732
-4,500
| -0.4% | -$2.23M | 0.34% | 58 |
|
|
2022
Q1 | $516M | Buy |
1,051,232
+124,600
| +13% | +$57M | 0.29% | 63 |
|
|
2021
Q4 | $430M | Sell |
926,632
-41,400
| -4% | -$17.4M | 0.26% | 69 |
|
|
2021
Q3 | $361M | Sell |
968,032
-30,600
| -3% | -$11.6M | 0.23% | 79 |
|
|
2021
Q2 | $381M | Sell |
998,632
-32,175
| -3% | -$12.3M | 0.24% | 75 |
|
|
2021
Q1 | $370M | Buy |
1,030,807
+7,600
| +0.7% | +$2.44M | 0.25% | 77 |
|
|
2020
Q4 | $329M | Sell |
1,023,207
-30,000
| -3% | -$9.21M | 0.23% | 81 |
|
|
2020
Q3 | $283M | Sell |
1,053,207
-16,700
| -2% | -$4.49M | 0.22% | 91 |
|
|
2020
Q2 | $281M | Buy |
1,069,907
+10,100
| +1% | +$2.69M | 0.24% | 81 |
|
|
2020
Q1 | $241M | Buy |
1,059,807
+186,300
| +21% | +$50.8M | 0.26% | 85 |
|
|
2019
Q4 | $264M | Sell |
873,507
-41,400
| -5% | -$11.4M | 0.27% | 74 |
|
|
2019
Q3 | $220M | Buy |
914,907
+7,766
| +0.9% | +$2.13M | 0.23% | 87 |
|
|
2019
Q2 | $256M | Sell |
907,141
-27,200
| -3% | -$7.43M | 0.28% | 71 |
|
|
2019
Q1 | $268M | Buy |
934,341
+20,200
| +2% | +$5.84M | 0.29% | 69 |
|
|
2018
Q4 | $240M | Buy |
914,141
+29,000
| +3% | +$7.97M | 0.31% | 69 |
|
|
2018
Q3 | $243M | Sell |
885,141
-33,100
| -4% | -$8.59M | 0.27% | 71 |
|
|
2018
Q2 | $219M | Buy |
918,241
+22,200
| +2% | +$5.14M | 0.25% | 81 |
|
|
2018
Q1 | $197M | Sell |
896,041
-137,300
| -13% | -$32.3M | 0.24% | 90 |
|
|
2017
Q4 | $233M | Sell |
1,033,341
-4,700
| -0.5% | -$1M | 0.25% | 85 |
|
|
2017
Q3 | $197M | Buy |
1,038,041
+11,300
| +1% | +$2.15M | 0.22% | 98 |
|
|
2017
Q2 | $193M | Buy |
1,026,741
+32,900
| +3% | +$5.91M | 0.23% | 97 |
|
|
2017
Q1 | $164M | Buy |
993,841
+204,200
| +26% | +$32.5M | 0.2% | 104 |
|
|
2016
Q4 | $114M | Buy |
789,641
+6,600
| +0.8% | +$884K | 0.18% | 123 |
|
|
2016
Q3 | $98.1M | Sell |
783,041
-5,700
| -0.7% | -$736K | 0.16% | 144 |
|
|
2016
Q2 | $104M | Buy |
788,741
+68,800
| +10% | +$9.41M | 0.17% | 136 |
|
|
2016
Q1 | $95.9M | Buy |
719,941
+202,500
| +39% | +$27.1M | 0.18% | 127 |
|
|
2015
Q4 | $72.2M | Buy |
517,441
+2,600
| +0.5% | +$358K | 0.17% | 129 |
|
|
2015
Q3 | $72.1M | Buy |
514,841
+41,600
| +9% | +$6.25M | 0.19% | 124 |
|
|
2015
Q2 | $77.7M | Buy |
473,241
+16,700
| +4% | +$2.67M | 0.2% | 117 |
|
|
2015
Q1 | $70.5M | Buy |
456,541
+150,900
| +49% | +$21.5M | 0.19% | 122 |
|
|
2014
Q4 | $38.4M | Sell |
305,641
-18,700
| -6% | -$2.31M | 0.14% | 164 |
|
|
2014
Q3 | $38.8M | Sell |
324,341
-7,900
| -2% | -$906K | 0.15% | 162 |
|
|
2014
Q2 | $35.8M | Buy |
332,241
+45,900
| +16% | +$4.73M | 0.13% | 179 |
|
|
2014
Q1 | $28.5M | Sell |
286,341
-32,300
| -10% | -$2.92M | 0.11% | 204 |
|
|
2013
Q4 | $29.4M | Sell |
318,641
-6,600
| -2% | -$586K | 0.11% | 204 |
|
|
2013
Q3 | $27.2M | Buy |
325,241
+1,700
| +0.5% | +$146K | 0.11% | 207 |
|
|
2013
Q2 | $26.5M | Buy |
+323,541
| New | +$24.2M | 0.12% | 200 |
|
Other funds holding ELV
VCM
VPM
Swiss National Bank's ELV Position: Q1 2026 in Review
Swiss National Bank increased its Elevance Health (ELV) stake by 5.7% in Q1 2026, buying an estimated $11.6M and bringing the position to 652,220 shares worth $191M. The position accounts for 0.11% of the portfolio, ranked #165.
Swiss National Bank first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $516M in Q1 2022. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Swiss National Bank held 652,220 shares of Elevance Health worth $191M as of Q1 2026.
- Swiss National Bank bought 35,160 Elevance Health shares in Q1 2026, an estimated $11.6M.
- Elevance Health made up 0.11% of Swiss National Bank's portfolio in Q1 2026, its #165 holding.
- Swiss National Bank first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
- Swiss National Bank's Elevance Health position peaked at $516M in Q1 2022.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Swiss National Bank's 13F filing for Q1 2026, filed 7 May 2026.